The issue of addressing potential nitrosamine impurities in medicines has been the focus at events taking place around the globe in recent months and will continue to do so throughout 2023.
USP and India's National Institutes for Pharmaceutical Education and Research work together to emphasize good-quality medicines and professional development.
India is a prominent player in today’s global pharmaceutical arena and a major contributor to the world’s supply of medicines. A large number of generics and OTC medicines in the U.S. are imported from India, which makes USP's collaborations with Indian pharma critical.
Tuberculosis (TB) is one of the world’s most prevalent diseases – it kills three people every minute. Although progress has been made in expanding access to treatment, the rate of multi-drug resistant TB cases has nearly doubled between 2011 and 2012. One factor driving drug resistance is poor quality drugs. Several global health organizations have partnered together to find a solution to ensure that safe and effective medicines are used in their treatment programs.
